Relationship and anticoagulant therapy between atrial fibrillation and pulmonary thromboembolism
-
摘要: 心房颤动(房颤)是临床上最常见的心律失常之一，其死亡率和发病率在很大程度上与血栓栓塞并发症相关。肺栓塞是心血管疾病死亡最常见的原因之一，是以各种栓子阻塞肺动脉或其分支为其发病原因的一组疾病或临床综合征的总称，而其中肺血栓栓塞症为肺栓塞最常见的类型。房颤和肺血栓栓塞有类似的高危因素，并且有越来越多的证据表明在房颤合并肺血栓栓塞的患者中，房颤可以通过右心房血栓形成、脱落导致肺血栓栓塞，反之房颤也可能是肺血栓栓塞产生的后果。目前，抗凝及预防血栓栓塞形成，仍是肺血栓栓塞合并房颤患者治疗中的重要策略。Abstract: Atrial fibrillation(AF) is one of the most common arrhythmias in clinical practice, and its mortality and morbidity are largely related to thromboembolic complications. Pulmonary embolism, one of the most common causes of death from cardiovascular diseases, is the general name of a group of diseases or clinical syndromes caused by various emboli blocking the pulmonary artery or its branches. Among them, pulmonary thromboembolism is the most common type of pulmonary embolism. Atrial fibrillation and pulmonary thromboembolism have similar risk factors, and there is increasing evidence that in patients with atrial fibrillation combined with pulmonary thromboembolism, atrial fibrillation can dislodge the right atrial thrombi leading to pulmonary thromboembolism, and atrial fibrillation may also be a consequence of pulmonary thromboembolism. At present, anticoagulation and prevention of thromboembolism are still important strategies in the treatment of patients with pulmonary thromboembolism complicated with atrial fibrillation.
-
Key words:
- atrial fibrillation /
- pulmonary thromboembolism /
- relationship /
- anticoagulant therapy
-
-
[1] Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio Thoracic Surgery(EACTS)[J]. Eur Heart J, 2021, 42(5): 373-498. doi: 10.1093/eurheartj/ehaa612
[2] Enga KF, Rye-Holmboe I, Hald EM, et al. Atrial fibrillation and future risk of venous thromboembolism: the Tromsø study[J]. J Thromb Haemost, 2015, 13(1): 10-16. doi: 10.1111/jth.12762
[3] 汪斌. 肺栓塞合并房颤的临床特点分析[D]. 郑州大学, 2019.
[4] Yang Y, Liu B, Taylor J, et al. Prevalence and clinical impact of atrial fibrillation in patients with pulmonary embolism[J]. South Med J, 2020, 113(2): 110.
[5] Barra SN, Paiva LV, Providência R, et al. Atrial fibrillation in acute pulmonary embolism: prognostic considerations[J]. Emerg Med J, 2014, 31(4): 308-312. doi: 10.1136/emermed-2012-202089
[6] Keller K, Prochaska JH, Coldewey M, et al. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism[J]. Thromb Res, 2015, 136(5): 899-906. doi: 10.1016/j.thromres.2015.08.024
[7] Kukla P, McIntyre WF, Koracevic G, et al. Relation of atrial fibrillation and right-sided cardiac thrombus to outcomes in patients with acute pulmonary embolism[J]. Am J Cardiol, 2015, 115(6): 825-830. doi: 10.1016/j.amjcard.2014.12.049
[8] Krajewska A, Ptaszynska-Kopczynska K, Kiluk I, et al. Paroxysmal atrial fibrillation in the course of acute pulmonary embolism: clinical significance and impact on prognosis[J]. Biomed Res Int, 2017, 2017(5049802): 110.
[9] 李延广, 时向民, 林琨, 等. 心房颤动血栓形成机制研究进展[J]. 心血管病学进展, 2015, 36(6): 691-695. doi: 10.3969/j.issn.1004-3934.2015.06.009
[10] Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm[J]. J Am Coll Cardiol, 2013, 61(8): 852-860. doi: 10.1016/j.jacc.2012.11.046
[11] Lohvinov YM, Mikhaliev KO, Zharinov OJ. Contemporary echocardiographic assessment of atrial appendages in non-valvular atrial fibrillation[J]. Kardiol Pol, 2015, 73(9): 701-710. doi: 10.5603/KP.2015.0162
[12] Kato Y, Fukuda Y, Miura S, et al. Right heart thrombosis with pulmonary embolism[J]. Intern Med, 2013, 52(15): 1745-1746. doi: 10.2169/internalmedicine.52.0076
[13] Aberg H. A study of atrial thrombosis and systemic embolism in a necropsy material[J]. Acta Med Scand, 1969, 185(5): 373-379.
[14] Waleed KB, Guan X, Li X, et al. Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonary embolism[J]. J Thorac Dis, 2018, 10(3): 1476-1482. doi: 10.21037/jtd.2018.01.177
[15] Ozer O, Sari I, Davutoglu V. Right atrial appendage: forgotten part of the heart in atrial fibrillation[J]. Clin Appl Thromb Hemost, 2010, 16(2): 218-220. doi: 10.1177/1076029608323088
[16] Cresti A, García-Fernández MA, Miracapillo G, et al. Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter[J]. J Am Soc Echocardiogr, 2014, 27(11): 1200-1207. doi: 10.1016/j.echo.2014.08.008
[17] Bassand JP, Virdone S, Goldhaber SZ, et al. Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation[J]. Circulation, 2019, 139(6): 787-798. doi: 10.1161/CIRCULATIONAHA.118.035012
[18] 陈胜华, 范松青. 中国人左、右心耳的形态学观察[J]. 南华大学学报(医学版), 2001, 10(3): 239-240. doi: 10.3969/j.issn.2095-1116.2001.03.009
[19] Contractor T, Mandapati R. Arrhythmias in patients with atrial defects[J]. Card Electrophysiol Clin, 2017, 9(2): 235-244. doi: 10.1016/j.ccep.2017.02.006
[20] Topuz M, Kılınc Y, Can C, et al. Atrial septal defect can mimic pulmonary thromboembolism after a major surgery[J]. Am J Emerg Med, 2016, 34(1): 121.e3-6.
[21] Sawyer CG, Bolin LB, Stevens EL, et al. Atrial fibrillation: its etiology, treatment and association with embolization[J]. South Med J, 1958, 51(1): 84-93. doi: 10.1097/00007611-195801000-00016
[22] Toplis E, Mortimore G. The diagnosis and management of pulmonary embolism[J]. Br J Nurs, 2020, 29(1): 22-26. doi: 10.12968/bjon.2020.29.1.22
[23] Ng AC, Adikari D, Yuan D, et al. The prevalence and incidence of atrial fibrillation in patients with acute pulmonary embolism[J]. PLoS One, 2016, 11(3): e0150448. doi: 10.1371/journal.pone.0150448
[24] Lutsey PL, Norby FL, Alonso A, et al. Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study[J]. J Thromb Haemost, 2018, 16(4): 670-679. doi: 10.1111/jth.13974
[25] 中华医学会心血管病学分会. 心律失常紧急处理专家共识[J]. 中华心血管病杂志, 2013, 41(5): 363-376. doi: 10.3760/cma.j.issn.0253-3758.2013.05.004
[26] Saliba W, Rennert G. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation[J]. Am J Med, 2014, 127(1): 45-52. doi: 10.1016/j.amjmed.2013.10.004
[27] 孙源君, Khalid Bin Waleed, 夏云龙. 心房颤动与肺栓塞的关系及治疗[J]. 中国循环杂志, 2018, 33(3): 307-309. doi: 10.3969/j.issn.1000-3614.2018.03.028
[28] 刘苗苗, 郭涛. 骨髓增生性肿瘤血栓事件的治疗现状[J]. 临床血液学杂志, 2021, 34(1): 9-12.
[29] 中国医学会呼吸病学分会肺栓塞与肺血管病学组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1088. doi: 10.3760/cma.j.issn.0376-2491.2018.14.007
[30] 韩琼, 郝美玲. 非瓣膜性心房颤动合并肺栓塞患者抗凝药物的比较[J]. 北方医学, 2020, 17(8): 106-107.
[31] 王子卿, 胡晓梅, 李芋锦, 等. 阿司匹林抵抗的真性红细胞增多症及原发性血小板增多症患者临床特征及凝血状态分析[J]. 临床血液学杂志, 2021, 34(11): 790-794.
[32] 卢东赫, 刘风华. 血栓弹力图肝素酶对比试验在下肢深静脉血栓中的应用[J]. 临床血液学杂志, 2019, 32(2): 96-102.
-
计量
- 文章访问数: 2173
- PDF下载数: 1014
- 施引文献: 0
下载: